Investigational COVID-19 Oral Tablet Vaccine Trial

AMR Clinical is conducting an investigational study for a COVID-19 oral tablet vaccine trial for healthy participants ages 18 and older who have completed their primary mRNA COVID-19 series.

Qualified participants must:

have received 2 or more mRNA shots against COVID-19, such as Moderna or Pfizer.

have had their last COVID-19 shot at least 6 months before taking part in the study

meet other study criteria

Qualified participants will receive all study-related care at no cost. Reimbursement is available up to $770.00 for study-related time and travel.

By participating in this investigational study, you'll have the opportunity to contribute to the ongoing efforts in the fight against COVID-19. Your involvement could potentially help advance the development of an oral tablet vaccine, which would be a significant step forward in combatting this global health crisis.

If you're interested in learning more about this trial, you can reach out to AMR today by calling (865) 305-3784 or visit their website at www.amrknoxville.com for more detailed information.